Evidence map›Paper›PMID 27375407›Full record

ArticleFrontiers in neuroscience2016

In utero and Lactational Exposure to Acetamiprid Induces Abnormalities in Socio-Sexual and Anxiety-Related Behaviors of Male Mice.

Kazuhiro Sano, Tomohiko Isobe, Jiaxin Yang, Tin-Tin Win-Shwe, Mitsuha Yoshikane, Shoji F Nakayama, Takaharu Kawashima, Go Suzuki, Shunji Hashimoto, Keiko Nohara and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. CaScientific reports · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kazuhiro SanoCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Tomohiko IsobeCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Jiaxin YangCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Tin-Tin Win-ShweCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Mitsuha YoshikaneCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Shoji F NakayamaCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Takaharu KawashimaCenter for Environmental Biology and Ecosystem Studies, National Institute for Environmental Studies Tsukuba, Japan.
Go SuzukiCenter for Health and Environmental Risk Research, National Institute for Environmental StudiesTsukuba, Japan; Center for Material Cycles and Waste Management Research, National Institute for Environmental StudiesTsukuba, Japan.
Shunji HashimotoCenter for Environmental Measurement and Analysis, National Institute for Environmental Studies Tsukuba, Japan.
Keiko NoharaCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
Chiharu TohyamaFaculty of Medicine, University of Tsukuba Tsukuba, Japan.
Fumihiko MaekawaCenter for Health and Environmental Risk Research, National Institute for Environmental Studies Tsukuba, Japan.
National Institute for Environmental Studies · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonicotinoids, a widely used group of pesticides designed to selectively bind to insect nicotinic acetylcholine receptors, were considered relatively safe for mammalian species. However, they have been found to activate vertebrate nicotinic acetylcholine receptors and could be toxic to the mammalian brain. In the present study, we evaluated the developmental neurotoxicity of acetamiprid (ACE), one of the most widely used neonicotinoids, in C57BL/6J mice whose mothers were administered ACE via gavage at doses of either 0 mg/kg (control group), 1.0 mg/kg (low-dose group), or 10.0 mg/kg (high-dose group) from gestational day 6 to lactation day 21. The results of a battery of behavior tests for socio-sexual and anxiety-related behaviors, the numbers of vasopressin-immunoreactive cells in the paraventricular nucleus of the hypothalamus, and testosterone levels were used as endpoints. In addition, behavioral flexibility in mice was assessed in a group-housed environment using the IntelliCage, a fully automated mouse behavioral analysis system. In adult male mice exposed to ACE at both low and high doses, a significant reduction of anxiety level was found in the light-dark transition test. Males in the low-dose group also showed a significant increase in sexual and aggressive behaviors. In contrast, neither the anxiety levels nor the sexual behaviors of females were altered. No reductions in the testosterone level, the number of vasopressin-immunoreactive cells, or behavioral flexibility were detected in either sex. These results suggest the possibility that in utero and lactational ACE exposure interferes with the development of the neural circuits required for executing socio-sexual and anxiety-related behaviors in male mice specifically.

Indexed as

acetamipridanxiety-related behaviorIn utero and lactational exposureneonicotinoidssociosexual behavior

Identifiers

PMID27375407
PMCPMC4891355
OpenAlexW2412267286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.